News Medicare coverage for CAR-T drugs on the horizon Medicare could soon cover CAR-T therapies under new proposals from the US’ Centers for Medicare & Medicaid Services (CMS), which aim to also gather real-world evidence to eventually inf
Events Partner Content Medicare Conference 2018 Improve Health Outcomes in Changing Medicare Landscape
News Clinton attacks Mylan over drug pricing Presidential hopeful criticises "outrageous" EpiPen price increase.
News Tenax trounced by phase 3 heart failure readout Shares in Tenax 85% of their value after its drug for patients with pulmonary hypertension caused by a form of heart failure flunked a phase 3 trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
